Journal of Critical Care
Volume 23, Issue 1 , Pages 41-49 , March 2008

Determinants of outcome in patients with a clinical suspicion of ventilator-associated pneumonia

  • John G. Muscedere, MD

      Affiliations

    • Department of Medicine, Queen's University, Kingston, Ontario, Canada K7L 2V7
    • Clinical Evaluation Research Unit, Kingston General Hospital, Kingston, Ontario, Canada K7L 2V7
    • ,
  • Chris McColl, MD

      Affiliations

    • Department of Medicine, Queen's University, Kingston, Ontario, Canada K7L 2V7
    • ,
  • Andrew Shorr, MD, MPH

      Affiliations

    • Pulmonary and Critical Care Medicine, Washington Hospital Center Georgetown University, Washington, DC 20010, USA
    • ,
  • Xuran Jiang, MSc

      Affiliations

    • Clinical Evaluation Research Unit, Kingston General Hospital, Kingston, Ontario, Canada K7L 2V7
    • ,
  • John Marshall, MD

      Affiliations

    • Department of Surgery, University of Toronto, Toronto, Ontario M5B 1W8
    • ,
  • Daren K. Heyland, MD, MSc

      Affiliations

    • Department of Medicine, Queen's University, Kingston, Ontario, Canada K7L 2V7
    • Clinical Evaluation Research Unit, Kingston General Hospital, Kingston, Ontario, Canada K7L 2V7
    • Corresponding Author InformationCorresponding author.
    • These authors have received unrestricted research grants for studies in ventilator-associated pneumonia unrelated to the present manuscript from Astra-Zeneca and Bayer Pharmaceuticals.
    • ,
  • for the Canadian Critical Care Trials Group

References 

  1. Cook DJ, Walter SD, Cook RJ, et al. Incidence of and risk factors for ventilator-associated pneumonia in critically ill patients. Ann Intern Med. 1998;129:433–440
  2. Vincent JL, Bihari DJ, Suter PM, et al. The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory Committee. JAMA. 1995;274:639–644
  3. Safdar N, Dezfulian C, Collard HR, et al. Clinical and economic consequences of ventilator-associated pneumonia: a systematic review. Crit Care Med. 2005;33:2184–2193
  4. Heyland DK, Cook DJ, Griffith L, et al. The attributable morbidity and mortality of ventilator-associated pneumonia in the critically ill patient. Am J Respir Crit Care Med. 1999;159:1249–1256
  5. Rello J, Ollendorf DA, Oster G, et al. for the VAP Outcomes Scientific Advisory Group Epidemiology and outcomes of ventilator-associated pneumonia in a large US database. Chest. 2002;122:2115–2121
  6. Girou E, Stephan F, Novara A, et al. Risk factors and outcome of nosocomial infections: results of a matched case-control study of ICU patients. Am J Respir Crit Care Med. 1998;157:1151–1158
  7. Bueno-Cavanillas A, Delgado-Rodriguez M, Lopez-Luque A, et al. Influence of nosocomial infection on mortality rate in an intensive care unit. Crit Care Med. 1994;22:55–60
  8. American Thoracic Society. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med. 2005;171:388–416
  9. Michaud S, Suzuki S, Harbarth S. Effect of design-related bias in studies of diagnostic tests for ventilator-associated pneumonia. Am J Respir Crit Care Med. 2002;166:1320–1325
  10. Waterer GW, Wunderink RG. Controversies in the diagnosis of ventilator-acquired pneumonia. Med Clin North Am. 2001;85:1565–1581
  11. Torres A, El-Ebiary M. Bronchoscopic BAL in the diagnosis of ventilator-associated pneumonia. Chest. 2000;117(4 Suppl 2):198S–202S
  12. Campbell GD. Blinded invasive diagnostic procedures in ventilator-associated pneumonia. Chest. 2000;117(4 Suppl 2):207S–211S
  13. Baughman RP. Protected-specimen brush technique in the diagnosis of ventilator-associated pneumonia. Chest. 2000;117(4 Suppl 2):203–206
  14. Fagon JY, Chastre J, Wolff M, et al. Invasive and noninvasive strategies for management of suspected ventilator-associated pneumonia: a randomized trial. Ann Intern Med. 2000;132:621–630
  15. Luna CM, Vujacich P, Niederman , et al. Impact of BAL data on the therapy and outcome of ventilator-associated pneumonia. Chest. 1997;111:676–685
  16. Heyland, DK, Dodek P, Muscedere J, et al. A randomized trial of combination versus monotherapy for the empiric treatment of suspected ventilator-associated pneumonia. Crit Care Med doi:10.1097/01.ccm.0B013E31816203D6.
  17. Sole Violan J, Fernandez JA, Benitez AB, et al. Impact of quantitative invasive diagnostic techniques in the management and outcome of mechanically ventilated patients with suspected pneumonia. Crit Care Med. 2000;28:2737–2741
  18. Ruiz M, Torres A, Ewig S, et al. Noninvasive versus invasive microbial investigation in ventilator-associated pneumonia: evaluation of outcome. Am J Respir Crit Care Med. 2000;162:119–125
  19. Calandra T, Cohen J. The international sepsis forum consensus conference on definitions of infection in the intensive care unit. Crit Care Med. 2005;33:1538–1548
  20. Heyland D, Dodek P, Day A, et al. for the Canadian Critical Care Trials Group A randomized trial of diagnostic techniques for suspected ventilator-associated pneumonia. N Engl J Med. 2006;355:2619–2630
  21. Marshall JC, Cook DJ, Christou NV, et al. Multiple organ dysfunction score: a reliable descriptor of a complex clinical outcome. Crit Care Med. 1995;23:1638–1652
  22. Pugin J, Auckenthaler R, Mili N, et al. Diagnosis of ventilator-associated pneumonia by bacteriologic analysis of bronchoscopic and nonbronchoscopic “blind” bronchoalveolar lavage fluid. Am Rev Respir Dis. 1991;143:1121–1129
  23. Singh N, Rogers P, Atwood CW, et al. Short-course empiric antibiotic therapy for patients with pulmonary infiltrates in the intensive care unit. A proposed solution for indiscriminate antibiotic prescription. Am J Respir Crit Care Med. 2000;162:505–511
  24. Hosmer DJ, Lemeshow S. Applied logistic regression. New York (NY): John Wiley and Sons; 1989;
  25. Nseir S, Di Pompeo C, Soubrier S, et al. Impact of ventilator-associated pneumonia on outcome in patients with COPD. Chest. 2005;128:1650–1656
  26. Papazian L, Bregeon F, Thirion X, et al. Effect of ventilator-associated pneumonia on mortality and morbidity. Am J Respir Crit Care Med. 1996;154:91–97
  27. Warren D, Shukla J, Olsen M, et al. Outcome and attributable cost of ventilator-associated pneumonia among intensive care unit patients in a suburban medical center. Crit Care Med. 2003;31:1312–1317
  28. Bone R. Towards an epidemiology and natural history of SIRS (systemic inflammatory response syndrome). Ann Intern Med. 2002;268:3452–3455
  29. Confalonieri M, Urbino R, Potena A, et al. Hydrocortisone infusion for severe community-acquired pneumonia: a preliminary randomized study. Am J Respir Crit Care Med. 2005;171:242–248
  30. Agbhat K, Diaz E, Munoz E, et al. Bacteremia in patients with ventilator-associated pneumonia is associated with increased mortality: a study comparing bacteremic vs. nonbacteremic ventilator associated pneumonia. Crit Care Med. 2007;35:2064–2070
  31. Fartoukh M, Maitre B, Honore S, et al. Diagnosing pneumonia during mechanical ventilation: the clinical pulmonary infection score revisited. Am J Respir Crit Care Med. 2003;168:173–179
  32. Luyt CE, Chastre J, Fagon JY. Value of the clinical pulmonary infection score for the identification and management of ventilator-associated pneumonia. Intensive Care Med. 2004;30:844–852
  33. Schurink CA, Van Nieuwenhoven CA, Jacobs JA, et al. Clinical pulmonary infection score for ventilator-associated pneumonia: accuracy and inter-observer variability. Intensive Care Med. 2004;30:217–224
  34. Croce MA, Swanson JM, Magnotti LJ, et al. The futility of the clinical pulmonary infection score in trauma patients. J Trauma. 2006;60:523–527[discussion 527-8]
  35. Seligman R, Meisner M, Lisboa T, et al. Decreases in procalcitonin and C-reactive protein are strong predictors of survival in ventilator-associated pneumonia. Crit Care. 2006;6(10):R125

☆ Supported by grants from the Canadian Institutes of Health Research and Physicians' Services Incorporated of Ontario and by unrestricted grants from Astra-Zeneca and Bayer.

PII: S0883-9441(08)00008-7

doi: 10.1016/j.jcrc.2007.12.007

Journal of Critical Care
Volume 23, Issue 1 , Pages 41-49 , March 2008

Article Tools

* Image Usage & Resolution